Fifty individuals have died in U.S. immigration detention since January 2025, a rate that has more than doubled since 2009. Concerns are ri...

Leading global private equity firms are in the running to acquire a substantial minority stake in Cloudnine, India's premier maternity and ...

Shubhanshu Shukla, India's first astronaut on the International Space Station, is training for the Gaganyaan mission. He draws on his IAF t...

Space stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...

Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...

As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...

China launched three astronauts to its space station. One astronaut will stay for a year, a record for the country. This mission supports C...

Venus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...

The Technology Development Board (TDB) has begun disbursing the first tranche of the Rs 1 lakh crore Research and Development Initiative (R...

Temasek and TPG Newquest are on the hunt for new financial partners for Cloudnine Hospitals, a premier name in mother and child healthcare....

Scientists studying naked mole rats discovered a gene linked to high levels of high molecular weight hyaluronic acid (HMW-HA), a substance ...

Last October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development of ⁠the therap...

Biocon Pharma Ltd has secured Health Canada approval for its micafungin for injection. This medication targets serious fungal infections in...

Biocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...

Planarian flatworms possess remarkable brain regeneration capabilities, thanks to specialized neoblast stem cells that can differentiate in...

Stem cell therapies are currently at a very preliminary stage of development, and only a few treatments have been approved by regulatory bo...